Research from Water Tower Research, Water Tower Research

Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Research from Water Tower Research

Metsera, Inc. (MTSR): Peeking at the Prospectus for the Next Obesity and Metabolic Diseases Biotech

Odyssey Therapeutics, Inc.(ODTX): Biotech Combating Ulcerative Colitis, or UC, Files for IPO

Sionna Therapeutics, Inc. (SION): Biotech for Patients with Cystic Fibrosis Filed for IPO

Equity Research Firm

Equity Bottom-Up

<ul><li>LifeVantage’s new MindBody GLP-1 System for weight loss is built upon the science that the company is predicated on, nutrigenomics and activating the body’s natural processes.</li><li>The products, which have been in development for well over a year, activate the L-cells in the body that are responsible for the production of the GLP-1 hormone.</li><li>In July, LifeVantage received results from in vitro testing it had done that were encouraging. </li></ul>

LifeVantage’s new MindBody GLP-1 System for weight loss is built upon the science that the company is predicated on, nutrigenomics and activating the body’s natural processes.The products, which have been in development for well over a year, activate the L-cells in the body that are responsible for the production of the GLP-1 hormone.In July, LifeVantage received results from in vitro testing it had done that were encouraging. 

LifeVantage Corporation: - Successful MindBody GLP-1 System Launch

Lifevantage

LifeVantage Corporation: - Successful MindBody GLP-1 System Launch